Covid-19, Education and Science, EU – Baltic States, Good for Business, Investments, Legislation, Lithuania, Markets and Companies, Medicine

The scheme had been approved under the State Aid Temporary Framework, the Commission said in a press release.

The scheme will be open to enterprises of all sizes that are capable to conduct coronavirus related R&D or production, except companies active in the primary agriculture, fishery and aquaculture, and financial sectors. The public support will take the form of direct grants.

The aim of the scheme is to enhance and accelerate the development and the production of coronavirus relevant products, such as medicinal products including vaccines, hospital and medical equipment including ventilators, protective clothing and equipment, diagnostic tools, disinfectants and data collection/processing tools.